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The respiratory tract pathogen Streptococcus pneumoniae needs to adapt to the different levels of carbon
dioxide (CO2) it encounters during transmission, colonization, and infection. Since CO2 is important for
various cellular processes, factors that allow optimal CO2 sequestering are likely to be important for pneu-
mococcal growth and survival. In this study, we showed that the putative pneumococcal carbonic anhydrase
(PCA) is essential for in vitro growth of S. pneumoniae under the CO2-poor conditions found in environmental
ambient air. Enzymatic analysis showed that PCA catalyzes the reversible hydration of CO2 to bicarbonate
(HCO3
), an essential step to prevent the cellular release of CO2. The addition of unsaturated fatty acids
(UFAs) reversed the CO2-dependent in vitro growth inhibition of S. pneumoniae strains lacking the pca gene
(pca), indicating that PCA-mediated CO2 fixation is at least associated with HCO3
-dependent de novo
biosynthesis of UFAs. Besides being necessary for growth in environmental ambient conditions, PCA-mediated
CO2 fixation pathways appear to be required for intracellular survival in host cells. This effect was especially
pronounced during invasion of human brain microvascular endothelial cells (HBMEC) and uptake by murine
J774 macrophage cells but not during interaction of S. pneumoniae with Detroit 562 pharyngeal epithelial cells.
Finally, the highly conserved pca gene was found to be invariably present in both CO2-independent and
naturally circulating CO2-dependent strains, suggesting a conserved essential role for PCA and PCA-mediated
CO2 fixation pathways for pneumococcal growth and survival.
The Gram-positive bacterium Streptococcus pneumoniae, or
pneumococcus, is a human respiratory tract pathogen that
contributes significantly to global mortality and morbidity. In
addition, it is an important asymptomatic colonizer of the
human nasopharynx, with carriage rates around 10% in adults
and over 40% in children (6). Pneumococcal colonization and
infection are closely linked, but knowledge of the factors that
contribute to transmission, carriage, disease, and transition
from carriage to disease is still limited. Research on compo-
nents that physically contribute to host-pathogen interactions,
such as capsular polysaccharides, adhesins, and toxins, has
provided valuable insights into the process of pneumococcal
pathogenesis (20). In contrast, the influence of environmental
factors on pneumococcal growth and survival remains fairly
unexplored.
S. pneumoniae needs to adapt to various aerobic and anaer-
obic conditions, reflecting the different niches it occupies dur-
ing transmission, colonization, and invasive disease. During
niche transition, oxygen (O2) levels change considerably. Lev-
els of O2 are 21% in ambient air, decrease to 10 to 15% in the
alveoli of the lungs, and are about 5% in resting cells. In
O2-rich conditions, S. pneumoniae expresses pyruvate oxidase
(SpxB), which generates acetyl-phosphate as a source of ATP
and hydrogen peroxide (H2O2) for interspecies competition at
the mucosal surfaces of the nasopharynx (41). The presence of
O2 is also a prerequisite for the pneumococcal X state (4, 14),
which is a physiological condition that allows for genetic trans-
formation and an adequate response to environmental stress
(32). Recently, it was shown that the fatty acid (FA) content of
the pneumococcal cell membrane (31) and the expression of 69
genes (8) change in response to the availability of O2. Finally,
changes in O2 levels can also affect production of the polysac-
charide capsule (48), which is the major pneumococcal viru-
lence determinant.
Similar to those of O2, the levels of carbon dioxide (CO2)
vary considerably among the different pneumococcal niches
inside and outside the host. Ambient levels of CO2 in the
environment are 0.038%, while CO2 levels inside the human
body, in particular in the lower respiratory tract, can reach 5%
or more. The importance of this gaseous compound for S.
pneumoniae is illustrated by the observation that the depletion
of CO2 from ambient air completely inhibits pneumococcal
growth (21). Moreover, about 8% of all clinical isolates require
a CO2-enriched environment for growth in laboratory condi-
tions (3). This intrinsic CO2 dependence of S. pneumoniae and
many other (micro)organisms is most likely related to an an-
abolic need for CO2 or bicarbonate (HCO3) during biosyn-
thesis of nucleic acids, amino acids, and FAs (1). Pathogens
can often sequester CO2 directly from host tissues, but in the
absence of sufficient levels of extracellular CO2, endogenous
CO2 needs to be enzymatically fixated. Carbonic anhydrases
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(CAs; EC 4.2.1.1) are enzymes that catalyze the reversible
reaction CO2  H2O 7 HCO3
  H. Because HCO3

cannot passively diffuse across biological membranes, its for-
mation significantly delays the release of intracellular CO2. At
least five different classes of CAs have been described, and
most eukaryotic, prokaryotic, and archaeal species express at
least one CA class (39, 40).
Genome analysis (39) has revealed that S. pneumoniae has
one putative CA, a -class CA that is highly conserved in all
available pneumococcal genome sequences. Pneumococcal CA
(PCA) is highly homologous to CAs in other streptococcal
species, such as Streptococcus pyogenes. The closest nonstrep-
tococcal PCA homologs are found in Mycobacterium species,
while PCA homologs in other respiratory tract pathogens such
as Neisseria meningitidis and Haemophilus influenzae are more
divergent (40). The aim of this study was to investigate the
functional characteristics of the pca gene and the encoded
PCA enzyme in S. pneumoniae and to establish the relevance
of PCA for pneumococcal growth and survival under CO2-
poor conditions in vitro. Further, we examined the importance
of PCA during host-pathogen interaction.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains that were used
in this study are listed in Table 1. S. pneumoniae strains were routinely grown
under static conditions in GM17 broth (23) or on blood agar (BA) plates
composed of Colombia agar (Oxoid) supplemented with 5% sheep blood (Bio-
trading). Cultures were incubated in a 5%-CO2 incubator at 37°C. To compare
growth under CO2-poor and -rich conditions, mid-log-phase cultures of pneu-
mococcal strains in CO2-enriched GM17 were diluted 50-fold in medium that
was exposed overnight to ambient air (0.038% CO2) or to ambient air enriched
with 5% CO2, respectively. Pneumococcal genetic transformation was performed
as described previously (10), and importantly, for preparation of competent S.
pneumoniae strains lacking the pca gene (pca), all media were first exposed to
ambient air enriched with 5% CO2. For transformation of the CO2-dependent
carriage strains, a 1:1 mixture of competence-stimulating peptide 1 (CSP-1) (100
ng/ml) and CSP-2 (100 ng/ml) was used. Viable-bacteria counts were derived
from CFUs after plating 10-fold serial dilutions in PBS. Escherichia coli strains
were routinely grown at 37°C on Luria Bertani (LB) agar plates or in LB broth
in a shaking incubator at 200 rpm. E. coli transformation was performed by the
CaCl2 competence method (35). Lactococcus lactis strains were routinely grown
on GM17 agar plates or in GM17 broth as static cultures at 30°C. L. lactis
transformation was performed by electroporation (23). The antibiotics and stock
solutions used for complementation studies were ampicillin, 100 g/ml; specti-
nomycin, 150 g/ml; kanamycin, 500 g/ml for S. pneumoniae and 50 g/ml for
E. coli; trimethoprim, 0.25 g/ml; chloroamphenicol, 2.5 g/ml for S. pneu-
moniae and 5 g/ml for L. lactis; adenine, 5 mg/ml in 0.05 M HCl; uracil, 2 mg/ml
in 1% sodium carbonate (Na2CO3); arginine, 20 mg/ml; aspartic acid, 20 mg/ml
(pH 7); palmitic acid or oleic acid, 200 mM in ethanol; sodium salicylate, 1 M;
and bovine liver catalase, 200,000 U/ml (Sigma).
DNA extraction and PCR conditions. Chromosomal DNA was isolated from S.
pneumoniae and E. coli broth cultures by cetyltrimethylammonium bromide
(CTAB) extraction as described previously (47). Plasmids were isolated from E.
coli and L. lactis broth cultures with a Qiaprep mini- or midikit (Qiagen). For
construction of directed-deletion mutants and glutathione S-transferase (GST)
fusion protein cloning, the proofreading Pwo DNA polymerase (Roche) was
used. For other PCR-based approaches, AmpliTaq DNA polymerase (Applied
Biosystems) was applied. The primers (Biolegio, Nijmegen, Netherlands) that
were used in this study are listed in Table S1 in the supplemental material.
Construction of pneumococcal mutants. Directed-deletion mutants of S. pneu-
moniae were generated by allelic exchange of the target gene with an antibiotic
resistance marker as described previously (10). Briefly, overlap extension PCR
was applied to insert the kanamycin or spectinomycin resistance cassette of the
pR410 or pR412 plasmid (Table 2), respectively, between the two 500-bp flank-
ing sequences surrounding the target gene. The overlap extension PCR products
were transformed into S. pneumoniae, and directed mutants were obtained by
selective plating. Correct integration of the antibiotic resistance cassette into the
target gene was validated by PCR. Gene deletion mutants were crossed back to
the wild-type strain, using chromosomal DNA of the mutant strains as the donor
during transformation. Since the flanking sequences of all the target genes used
in this study were homologous in the R6, D39, and TIGR4 strains, gene deletions
were introduced into D39 and TIGR4 by transformation with the PCR-amplified
gene deletions and 500-bp flanking sequences of the R6 mutant derivatives.
Plasmid construction. All plasmids used in this study are listed in Table 2. To
obtain the plasmids for complementation of the CO2-dependent growth defect of
the pca strains, the pca gene of S. pneumoniae TIGR4 and the ecca gene
(ECDH10B_106) of E. coli DH5 were PCR amplified with the PBNISPCA_L/
TABLE 1. Bacterial strains used in this study
Species and strain Relevant characteristics Reference
S. pneumoniae
R6 Wild-type strain, unencapsulated 19
D39 Wild-type strain, serotype 2 25
TIGR4 Wild-type strain, serotype 4 45
R6pca spr0026 Spr This study
D39pca SPD_0030 Spr This study
TIGR4pca SP_0024 Spr This study
R6bga::nisRK Nisin-responsive R6 strain; spr0565::nisRK Tmpr 23
R6bga::nisRKpca Nisin-responsive R6 strain; spr0565::nisRK spr0026 Tmpr Spr This study
R6pcaspxB spr0026 spr0642 Spr Kmr This study
TIGR4pcaspxB SP_0024 SP_0730 Spr Kmr This study
TIGR4cps Unencapsulated TIGR4 strain; SP_0343-0365 Kmr 11
TIGR4cpspca Unencapsulated TIGR4 strain; SP_0343-0365 SP_0024 Kmr Spr This study
D39cps Unencapsulated D39 strain; SPD_0312-0333 Kmr 11
D39cpspca Unencapsulated D39 strain; SPD_0312-0333 SPD_0030 Kmr Spr This study
H23 CO2-dependent carriage isolate Laboratory collection
H26 CO2-dependent carriage isolate Laboratory collection
E. coli
DH5 Cloning strain 17
BL21 Expression strain Novagen
L. lactis
NZ9000 Cloning strain 24
Spr, spectinomycin resistant; Tmpr, trimethoprim resistant; Kmr, kanamycin resistant.
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PBNISPCA_R and PB_NISECCA_L/PB_NISECCA_R primer pairs, respec-
tively. The PCR products were cloned into the pCR2.1 cloning vector of a TA
cloning kit (Invitrogen) to obtain pCR2.1-PCA_L and pCR2.1-ECCA, respec-
tively. In the next step, the genes were excised by BsaI/EcoRI digestion and
ligated to the NcoI/EcoRI-digested pNG8048 plasmid to obtain pUO3 and
pUO1, respectively. To obtain the plasmid for overproduction of GST-PCA, the
pca gene of S. pneumoniae TIGR4 was PCR amplified with the PBPCA_S/
PBPCA_E primer pair and cloned into pCR2.1 to obtain pWA1. In the next step,
the pca gene was excised by BamHI/EcoRI digestion and subcloned behind the
GST gene in a BamHI/EcoRI-digested pGEX-1N vector to obtain pWA4. Clon-
ing of the pCR2.1 and pGEX-1N plasmids was performed in E. coli DH5, and
cloning of the pNG8048E plasmids was performed in L. lactis NZ9000. The
nucleotide sequences of the PCR products in the pCR2.1 plasmid were con-
firmed by sequencing.
Production and purification of recombinant GST-PCA. For GST-PCA pro-
duction, an overnight culture of E. coli BL21 (pWA4) was diluted 50-fold in
prewarmed (37°C) 2 LB supplemented with 0.5% glucose. At an optical density
at 600 nm (OD600) of 0.6 to 0.8, 0.1 mM isopropyl--D-thiogalactopyranoside
(IPTG) was added, and cultures were shifted to room temperature. After 4 h,
cells were placed on ice, pelleted by centrifugation, resuspended in ice-cold lysis
buffer (50 mM Tris-HCl [pH 7.5], 300 mM NaCl, 0.5 mM dithiothreitol [DTT],
1.5 mM MgCl2, 0.2 mM EDTA, 1% Triton X-100) with 1 protease inhibitor
mixture (Complete Mini; Roche Applied Science) to a cell density equivalent to
an OD600 of 100, and lysed by sonication. Insoluble debris in the lysate was
removed by centrifugation at 16,000  g for 10 min at 4°C, and the supernatant
was incubated overnight with prewashed (1 PBS) glutathione Sepharose 4 Fast
Flow beads (GE Healthcare) at 4°C. Nonspecifically bound proteins were re-
moved by washing the beads three times with lysis buffer for 15 min at 4°C.
GST-PCA was eluted with elution buffer (50 mM Tris-HCl [pH 8.0], 300 mM
NaCl, 10 mM glutathione, and 0.5 mM DTT). The eluate was dialyzed against 50
mM Tris, pH 7.5. The protein concentration in the GST-PCA solution was
determined with a bicinchoninic acid (BCA) protein assay kit (Pierce).
Carbonic anhydrase activity assay. The activity of CAs was determined by the
changing-pH/dye indicator method (22) on an RX.2000 rapid-mixing stopped-
flow unit (Applied Photophysics, United Kingdom). Briefly, enzyme samples
were diluted in reaction buffer at pH 7.5 (50 mM HEPES [pH 7.5], 200 mM
phenol red, and 200 mM Na2SO4) or at pH 8.4 (50 mM TAPS [pH 8.4], 200 mM
m-cresol purple, and 200 mM Na2SO4), and the reaction was initiated by the
addition of an equivalent amount of CO2-saturated water. The subsequent res-
toration of CO2/HCO3 balance was monitored by the color conversion of the
pH-sensitive dye indicators at 558 nm (pH 7.5) or 578 nm (pH 8.4). All reactions
were performed at 25°C. The CA activities of GST-PCA and human CA II
([hCAII] Sigma) were measured at final concentrations of 100 g/ml and 0.5
g/ml, respectively. When appropriate, 50 mM Tris-HCl (pH 7.5) and dimethyl
sulfoxide (DMSO) were included as nonenzymatic controls. The stock solutions
for CA inhibition studies were 100 mM acetazolamide ([AZA] Sigma) and 100
mM ethoxyzolamide ([EZA] Sigma) in DMSO.
Cell lines, culture conditions, and host-pathogen studies. The human pharyn-
geal epithelial cell line Detroit 562 (CCL-138; ATCC) was routinely grown in
RPMI 1640 medium without phenol red (Invitrogen, Netherlands) supple-
mented with 1 mM sodium pyruvate and 10% fetal calf serum (FCS). The human
brain microvascular endothelial cell (HBMEC) line was cultivated in RPMI 1640
medium supplemented with 10% FCS, 10% Nu-Serum, 2 mM L-glutamine, 1
mM sodium pyruvate, 1% minimal essential medium (MEM)-vitamins, and 1%
nonessential amino acids (42). Prior to infection, HBMEC monolayers were
incubated for 1 h in culture medium with 10 ng/ml of tumor necrosis factor alpha
(TNF-). The murine macrophage-like cell line J774 (TIB 67; ATCC) was
cultured in Dulbecco’s modified Eagle’s medium (DMEM) GlutaMAX-I (In-
vitrogen, Netherlands) with 10% FCS. All cells were cultured in a 5%-CO2
incubator at 37°C.
Pneumococcal adherence, invasion, and intracellular survival studies were
performed essentially as described previously (7, 11, 16). Briefly, monolayers of
J774, Detroit 562, or HBMECs were infected with bacteria in 5%-CO2-enriched
culture medium with only 1% FCS (infection medium). Subsequently, the pneu-
mococci were allowed to adhere to the cells for 0.5 h, 1 h, or 2 h, respectively, and
nonadherent bacteria were removed by washing. To quantify adherence, host
cells were detached from the wells and lysed with 0.025% Triton X-100 or 1%
saponin and trypsin-EDTA (0.05%-0.02%). To determine the level of invasion
into the host cells, extracellular S. pneumoniae cells were killed by a 1-h incu-
bation with 1 ml 5%-CO2-enriched infection medium supplemented with genta-
micin (200 g/ml) and penicillin G (10 g/ml) before cells were lysed. To
examine intracellular survival, cells were infected and treated with gentamicin
and penicillin G as described above, after which cells were washed once and fresh
5%-CO2-enriched medium containing gentamicin (13.34 g/ml) and penicillin G
(0.67 g/ml) (1/15 of beginning antibiotic concentration) was added to each well
for prolonged incubation. For all in vitro cell culture studies, the pneumococcal
wild-type and mutant strains grew comparably in infection medium alone. Re-
sults were corrected mathematically to account for small differences in count in
the initial inoculum.
In vivo colonization and bacteremia experiments. Bacteremia and nasopha-
ryngeal colonization experiments with mice were conducted with 9-week-old
female outbred CD-1 mice (Harlan, Horst, Netherlands) as described recently
(18). Briefly, for the colonization experiments, 1 106 CFU in 10 l of PBS were
administered to the nostrils of groups of five mice for each strain, and bacteria
were recovered from the nasopharynx by flushing the nose with 2 ml of sterile
PBS at 96 h. Bacteremia experiments were performed twice with groups of at
least five mice for each strain. Mice were infected intravenously in the tail vein
with 1  106 CFU in 100 l of PBS, and bacteria were recovered from the blood
by retro-orbital puncture. For mice in which no bacteria were found, a lower limit
of detection (22 CFU/ml) was used. Results were corrected mathematically to
account for small differences in bacterial count in the initial inoculum. All
experiments were performed with the approval of the Animal Experimentation
Committee (DEC) of the Radboud University Nijmegen Medical Centre.
In silico analysis. The subcellular location of PCA enzyme was predicted by
various online prediction servers, such as PSORTb (http://www.psort.org) and
TMHMM (http://www.cbs.dtu.dk/services/TMHMM). Conservation of the pca
gene and PCA protein was performed by the genomic BLAST service on the
website of the National Center for Biotechnology Information (NCBI) of the
U.S. National Library of Medicine (http://www.ncbi.nlm.nih.gov/).
Statistical analysis. For in vitro host-pathogen studies, data were analyzed
using an unpaired Student’s t test, with P values of 0.05 considered significant.
All statistical analyses were performed using GraphPad Prism version 4.0.
RESULTS
The pca gene is required for pneumococcal growth under
CO2-poor conditions. To determine the importance of the pca
gene for pneumococcal growth, pca deletion mutants (pca)
were constructed from three S. pneumoniae strains, i.e., R6
(spr0026), D39 (SPD_0030), and TIGR4 (SP_0024). All
pca strains were able to grow normally on BA plates and
Trypticase soy broth (TSB) agar plates supplemented with
catalase (Trypticase soy agar [TSA]) under ambient air en-
riched with 5% CO2 (data not shown). In vitro growth rates in
TABLE 2. Plasmids used in this study
Plasmid Relevant characteristicsa Reference
pR410 Donor for kanamycin resistance
cassette
43
pR412 Donor for spectinomycin resistance
cassette
28
pCR2.1 Cloning vector; Apr Kmr Invitrogen
pGEX-1N Expression vector with N-terminal
GST tag; Apr
Novagen
pNG8048E Expression vector with nisin-
inducible promoter; Car
23
pWA1 pCR2.1 with pca gene, BamHI site;
Apr Kmr
This study
pWA4 pGEX-1N with gst-pca construct; Apr This study
pCR2.1-PCA_L pCR2.1 with pca gene, BsaI site; Apr
Kmr
This study
pCR2.1-ECCA pCR2.1 with ecca gene, BsaI site;
Apr Kmr
This study
pUO1 pNG8048 with ecca gene behind
nisin-inducible promoter; Car
This study
pUO3 pNG8048 with pca gene behind
nisin-inducible promoter; Car
This study
a Apr, ampicillin resistant; Kmr, kanamycin resistant; Car, chloroamphenicol
resistant.
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5%-CO2-enriched GM17 broth medium were similar for the
pca and wild-type strains, with cultures reaching an OD620 of
0.3 or more (Fig. 1A, left panel). In GM17 broth medium that
was exposed to ambient air, the wild-type strains were also able
to reach a high OD620. In contrast, growth of all pca strains
under these CO2-poor (0.038%) growth conditions was atten-
uated, and cultures did not reach an OD620 above 0.1 (Fig. 1A,
right panel). Growth of the pca strains under CO2-poor con-
ditions was also impaired on TSA plates and reduced on BA
plates (data not shown).
To exclude polar effects due to disruption of the pca gene,
we provided the pca gene in trans on the pUO3 plasmid
behind a nisin-inducible promoter. Induction of pca gene
expression by the addition of nisin restored growth of the
nisin-responsive R6bga::nisRKpca (pUO3) strain in CO2-
poor GM17 broth (Fig. 1B). Introduction of the pUO1 plasmid
with the gene for E. coli carbonic anhydrase (ECCA) (12) into
R6bga::nisRKpca also reversed the CO2 dependence of this
strain (Fig. 1B). Interestingly, complementation by ECCA did
not appear to require induction with nisin. Because pUO1
could not restore the CO2 dependence of the R6pca strain
lacking the NisRK sensor for nisin (data not shown), it is likely
that autoinduction of the NisRK two-component signal trans-
duction system resulted in expression of small but sufficient
amounts of ECCA.
PCA has carbonic anhydrase activity. The PCA enzyme was
further characterized with enzymatic activity and inhibition
assays. To facilitate the measurement of PCA enzymatic activ-
ity, PCA was overproduced as a GST fusion protein in E. coli.
Since no endogenous E. coli CA activity was detected in the
lysates of control cells expressing only the GST protein, the CA
activity in E. coli cells expressing GST-PCA can be fully as-
cribed to the presence of the recombinant protein (data not
shown). The affinity-purified recombinant GST-PCA protein
catalyzed the conversion of CO2 to HCO3
 at pH 8.4, whereas
the enzymatic activity was almost completely abrogated at pH
7.5 (Fig. 2A). Sulfonamides such as AZA and EZA are broad-
range CA inhibitors that are active against most CAs (39),
including the homologous Rv1284 CA in Mycobacterium tuber-
culosis (29). Interestingly, the presence of 100 M AZA or 100
M EZA did not reduce the CA activity of recombinant GST-
PCA, whereas that of hCAII was completely inhibited (Fig.
FIG. 1. Disruption of the pca gene in S. pneumoniae leads to CO2-dependent growth inhibition. (A) Growth characteristics of the S.
pneumoniae R6, D39, and TIGR4 wild-type and pca strains in CO2-rich and CO2-poor GM17 broth medium. (B) Growth of the S. pneumoniae
R6bga::nisRK pca strain harboring either pNG8048E (empty vector), pUO1 (ecca), or pUO3 (pca) in CO2-poor GM17 broth medium without
(nis) and with (nis) 20 ng/ml nisin. Growth of the pneumococcal cultures was monitored by recording the OD620. All curves in the graph present
the averages of the results of three independent growth experiments.
FIG. 2. Enzymatic activity and inhibition studies of recombinant
GST-PCA. (A) The CA activity of GST-PCA (100 g/ml) was measured
by the changing-pH/dye indicator method at pH 7.5 and pH 8.4. (B) In-
hibitory effect of the sulfonamides AZA (100 M) and EZA (100 M) on
the CA activity of GST-PCA at pH 8.4. Under all conditions tested,
hCAII (0.5 g/ml) and nonenzymatic reactions were included as positive
and negative controls, respectively. The curves for the nonenzymatic con-
trol reactions of the inhibition study overlapped with the curves for hCAII
with an inhibitor and for the clarity of the graph were not displayed. All
curves in the graphs present the averages of the results of three indepen-
dent CA activity assays. Abs., absorbance.
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2B). Since both compounds also did not induce CO2 depen-
dence in S. pneumoniae wild-type strains (data not shown),
these sulfonamides are unlikely to have high affinity for PCA.
PCA is linked to UFA biosynthesis. The biosynthesis path-
ways for nucleic acids, fatty acids, and several amino acids all
contain an essential HCO3
-dependent carboxylation step that
could potentially account for the observed growth defect of
microbial CA mutants in CO2-poor conditions (1). To investi-
gate if one or more of these carboxylation steps are responsible
for the growth inhibition of the S. pneumoniae pca strains in
CO2-poor GM17 broth medium, we complemented pneumo-
coccal cultures with sodium hydrogen carbonate (NaHCO3) or
various metabolic intermediates (i.e., adenine, uracil, arginine,
aspartic acid, palmitic acid [in 0.1% Tween 40], or oleic acid [in
0.1% Tween 40]) (Fig. 3A). As predicted, NaHCO3 fully re-
versed growth of the S. pneumoniae TIGR4pca strain under
CO2-poor conditions. The unsaturated fatty acid (UFA) oleic
acid was the only metabolic intermediate that could partially
restore growth as well, although not to the same level as
NaHCO3. Other sources of UFAs, such as Tween 20 and
Tween 80 (30), could also (partially) reverse the CO2 depen-
dence of the S. pneumoniae TIGR4pca strain (Fig. 3B). In
contrast, the saturated fatty acid (SFA) palmitic acid (Fig. 3A)
or Tween 40 (Fig. 3B), which is a Tween derivative that is
solely composed of SFA, was ineffective.
Because supplementation with SFAs could not reverse the
CO2-dependent growth inhibition of the pca strains, CO2
fixation by PCA appears to be essential when insufficient UFAs
are available in the growth medium. The synthesis of UFAs
and SFAs in S. pneumoniae occurs essentially by the same
pathway (27). The dependency of the pca strains on UFA
supplementation for growth under CO2-poor conditions there-
fore suggests that under this condition UFAs are more readily
depleted. Recently, it was reported that the reactive oxygen
species (ROS) scavenger salicylate increased the unsaturation
index of bacterial-membrane fatty-acyl chains under aerobic
(thus CO2-poor) growth conditions by protecting UFAs
against endogenous oxidative stress (31). In line with this ob-
servation, cultures of the S. pneumoniae R6pca and
TIGR4pca strains grown under CO2-poor conditions reached
an almost-2-fold-higher optical density when supplemented
with salicylate (Fig. 4A). Neutralization of endogenous H2O2,
which also plays an important role in lipid peroxidation (38),
through the addition of high concentrations of catalase re-
stored growth of the S. pneumoniae R6pca and TIGR4pca
strains to an almost-3-fold-higher optical density (Fig. 4B).
Despite the involvement of pyruvate oxidase (SpxB) in endog-
enous H2O2 production (41), disruption of the spxB gene in the
TIGR4pca and R6pca strains did not restore growth to the
same level as that in the catalase-complemented cultures (Fig.
4B). Moreover, the addition of catalase still promoted growth
of the S. pneumoniae TIGR4spxBpca and R6spxBpca
strains (Fig. 4B).
PCA is required for intracellular survival inside host cells.
Membrane fatty acids are essential for pneumococcal growth
and survival (26) and are important targets for host defense
mechanisms (38). Because our experiments suggest that PCA
activity and UFA biosynthesis are linked, we investigated the
specific contribution of PCA to pneumococcal host-pathogen
interactions. To identify PCA-mediated effects on the interac-
tion of S. pneumoniae with host cells, we assessed the ability of
the pca strains to adhere to, invade, and survive in different
cell lines. First, we studied the interaction of S. pneumoniae
with human pharyngeal epithelial Detroit 562 cells, which are
representative of the host cells encountered by S. pneumoniae
during colonization of human upper airways. Disruption of the
pca gene in the unencapsulated (cps) derivative of the S.
pneumoniae TIGR4 strain did not lead to decreased adherence
to (Fig. 5A) or invasion of (Fig. 5C) these epithelial cells.
However, at 1 h after pneumococcal invasion of the host cells,
we observed a statistically significant 1.3-fold reduction in in-
tracellular survival of the TIGR4cpspca strain in Detroit
562 cells (Fig. 5E). Next, we examined the role of PCA during
interaction of S. pneumoniae with the HBMEC line. Endothe-
lial cells are the main component of the blood-brain barrier,
and penetration of this barrier by pathogens can lead to men-
FIG. 3. Bicarbonate and oleic acid revert the CO2 dependence of pca strains. (A) Growth of the S. pneumoniae TIGR4pca strain in
CO2-poor GM17 broth medium supplemented with NaHCO3 (10 mM), adenine (200 g/ml), uracil (200 g/ml), arginine (200 g/ml), aspartic acid
(200 g/ml), palmitic acid (0.01 mM in 0.1% Tween 40), or oleic acid (0.01 mM in 0.1% Tween 40). (B) Growth of the S. pneumoniae TIGR4pca
strain in CO2-poor GM17 broth medium with 0.1% Tween 20, Tween 40, or Tween 80. The growth of all pneumococcal broth cultures was
monitored by recording the OD620. All curves in the graph present the averages of the results of three independent growth experiments.
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ingitis. Adherence to HBMEC was not significantly different
between the TIGR4cps and TIGR4cpspca strains (Fig.
5A). In contrast, the number of viable intracellular bacteria
that could be recovered from HBMECs directly after pneumo-
coccal invasion was reduced 7-fold for the TIGR4cpspca
strain compared to that of the TIGR4cps strain (Fig. 5C).
Interestingly, at 2 and 4 h after invasion, the relative decreases
in the numbers of viable intracellular bacteria were equal for
the two strains (Fig. 5F). Finally, we investigated the role of
PCA during interaction of S. pneumoniae with mouse J774
macrophage cells, which are primary immune cells important
for clearance of bacterial infections. Exposure of J774 cells to
TIGR4cps induced morphological and phenotypical changes
in J774 cells, such as surface detachment and cell lysis, making
readout unreliable and leading to nonreproducible results.
J774 interaction studies were therefore continued with the S.
pneumoniae D39cps and D39cpspca strains. Although dis-
ruption of the pca gene had no significant effect on the binding
of S. pneumoniae by host immune cells (Fig. 5B), the number
of viable intracellular bacteria directly after uptake by the
macrophages was 2-fold lower for the D39cpspca strain
than for the D39cps strain (Fig. 5D). Moreover, temporal
monitoring revealed that phagocytic killing of intracellular bac-
teria continued to be significantly faster for the D39cpspca
strain than for the D39cps strain (Fig. 5G). Despite the in
vitro contribution of PCA to pneumococcal intracellular sur-
vival, no significant difference between the S. pneumoniae
TIGR4 wild-type and TIGR4pca strains was observed in
mouse models of pneumococcal nasopharyngeal carriage and
bacteremia (see Fig. S1 in the supplemental material).
The pca gene is present in CO2-dependent circulating
strains. The pca gene appears to be a highly conserved gene,
which is present in all 11 complete and 18 draft S. pneumoniae
genomes that are currently available in the public databases.
Still, about 8% of all S. pneumoniae isolates from various
sources have been reported as CO2 dependent (3). To exclude
the possibility that the pca gene is absent in these circulating
strains, we investigated whether the CO2 dependence of these
isolates is related to the absence of a functional pca gene. Two
out of 126 carriage strains (H23 and H26) isolated from
healthy Venezuelan children (our unpublished data) did not
grow on BA and TSA plates unless the environment was en-
riched with 5% CO2. PCR analysis indicated that the pca gene
was present in both CO2-dependent strains (Table 3), and
genetic transformation of these strains with chromosomal
DNA from both the S. pneumoniae R6 wild-type and R6pca
strains resulted in CO2-independent colonies (Table 3). These
results suggest that the observed CO2 dependence of the H23
and H26 strains is associated with a genetic defect or a missing
gene other than pca. In addition, further phenotypical charac-
terization of these strains showed that their CO2 dependence
was different from that of the S. pneumoniae pca strains used
in this study. Although both strains were completely CO2 de-
pendent for growth on BA plates, the H23 strains reached high
optical densities in CO2-poor GM17 broth medium. In con-
trast, the H26 strain did not grow at all in CO2-poor GM17
broth medium, not even when it was supplemented with UFA
(Tween 80) (Table 3).
DISCUSSION
The respiratory tract pathogen S. pneumoniae needs to
adapt to the various conditions it encounters during transmis-
sion, colonization, and disease. Currently, relatively little is
known about the genetic and metabolic factors that contribute
to an adequate response of this bacterium to changes in CO2
availability. In this study, we showed that the putative carbonic
anhydrase in S. pneumoniae has an important role for growth
in CO2-poor conditions.
Our experiments clearly showed that the pca gene encodes a
functionally active carbonic anhydrase. All the pca strains
were growth deficient in CO2-poor conditions but could be
complemented by the addition of HCO3
, the expected end
product of PCA enzymatic activity. In addition, growth of the
pca strains could be restored by in trans expression of the
FIG. 4. Scavengers for endogenous ROS delay the CO2-dependent
growth defect of pca strains. (A) Growth of the the R6 and TIGR4
S. pneumoniae pca strains in CO2-poor GM17 broth medium without
(sal) or with 5 mM (sal) sodium salicylate. (B) Growth of the S.
pneumoniae R6 and TIGR4pca and pcaspxB strains in CO2-poor
GM17 broth medium without (cat) or with (cat) 10,000 U/ml of
catalase. The growth of all pneumococcal broth cultures was moni-
tored by recording the OD620. All curves in the graphs present the
results of a single experiment that are characteristic of those for three
independent growth experiments.
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well-characterized homologous -CA (ECCA) from E. coli.
Finally, recombinant GST-PCA was able to catalyze the con-
version of CO2 to HCO3. Interestingly, PCA did not appear to
be active at the physiological pH of 7.5. This is not unusual for
-CAs and has been observed for ECCA and the H. influenzae
CA (HICA). Most likely, this pH-dependent behavior is linked
to the pH-dependent coordination of Zn2 in the active site
(13). Furthermore, both ECCA and HICA appear to have an
alternative bicarbonate binding site that renders the enzyme
inactive at physiological pH when sufficient substrate is present
(13). Although PCA appears to miss essential amino acids that
form the alternative bicarbonate binding site, it is also not
unlikely that differences exist between its CA activity in enzy-
matic assays and in physiological conditions. Another striking
characteristic of PCA is its lack of affinity for broad-range
carbonic anhydrase inhibitors. This indicates that this enzyme
is deviant from other well-characterized CAs, which is not
surprising, as there is huge variation among the different CAs,
and CA inhibitors were often developed against unrelated
hCAs. In fact, differences between PCA and hCAs could ben-
efit the therapeutic potential of PCA inhibitors.
Our metabolic complementation experiments revealed, in anal-
ogy to the role of CAs in other microorganisms (1, 5), that the
cellular function of PCA in CO2-poor conditions is at least linked
to FA biosynthesis. This implies that PCA provides HCO3
 re-
FIG. 5. PCA is required for invasion and intracellular survival in host cells. (A and B) In vitro adherence of the TIGR4cpspca strain to
Detroit 562 cells and HBMECs (A) and binding of the D39cpspca strain by J774 cells (B). The relative adherence and binding efficiencies were
correlated to those of the TIGR4cps and D39cps strains, respectively. (C and D) Invasive properties of the TIGR4cpspca strain toward
Detroit 562 cells and HBMECs (C) and uptake of the D39cpspca strain by J774 cells (D). The relative invasion and uptake efficiencies were
correlated to the number of viable intracellular cells of the TIGR4cps and D39cps strains, respectively. (E and F) Intracellular survival kinetics
of the TIGR4cps and TIGR4cpspca strains in Detroit 562 cells (E) and HBMECs (F). (G) Phagocytic killing of the D39cps and D39cpspca
strains in J774 cells. Intracellular survival and phagocytic killing were correlated to viable-bacteria counts at time zero. *, statistically significant
differences (P  0.05).
TABLE 3. Characteristics of CO2-dependent carriage isolates
Straina
Transformation
(CFU/ml) with
DNA from:
Growth on or in indicated plate or brothc
R6 R6pca BAplates TSA plates
GM17
broth
GM17
broth (0.1%
Tween 80)
H23 19,800 14,900    
H26 67 67    
a Both strains carry the pca gene.
b No. of colonies growing on BA plates under CO2-poor conditions.
c , growth; , no growth.
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quired for the carboxylation of acetyl coenzyme A (acetyl-CoA)
by acetyl-CoA carboxylase to form malonyl-CoA, which is the first
committed step of FA biosynthesis (15). We did not observe a
stimulating effect of any of the other tested metabolic intermedi-
ates on the growth of the S. pneumoniae pca strains in CO2-poor
GM17 broth medium. This implies that GM17 medium contains
limiting amounts of UFAs but sufficient levels of the other me-
tabolites to support growth. Based on the UFA supplementation
experiments and previous observations of other microorganisms
(1, 5), we can predict that other carboxylation reactions, e.g.,
those involved in biosynthesis of some amino acids, pyrimidines,
and purines, also depend on PCA activity when CO2 levels are
low. Still, we feel that support of UFA biosynthesis is one of the
most relevant aspects of PCA function. Although S. pneumoniae
is able to tolerate low levels of membrane SFAs, insufficient
UFAs lead to decreased cell viability (2). In ambient-air condi-
tions, both environmental and cellular UFAs are prone to oxida-
tion and can be replaced only by the PCA-supported de novo
biosynthesis of UFAs. In addition, endogenous production of
ROS by S. pneumoniae itself leads to increased cellular UFA
peroxidation (31). Due to the transient phenotype of the pca
mutation, it was not possible to perform a straightforward exper-
iment to directly link the disruption of the pca gene to an alter-
ation in the membrane FA composition or increased ROS sensi-
tivity. In the absence of CO2, the pca strains do not grow,
whereas in the presence of CO2, the pca and wild-type strains
are phenotypically identical. In analogy with studies of S. pneu-
moniae UFA auxotrophs (27), we did attempt to complement
cultures of the pca strains in CO2-poor conditions with UFAs to
restore growth and allow characterization of membrane FAs.
However, supplementation of cultures of the pneumococcal wild-
type andpca strains with UFAs completely repressed expression
of the FA biosynthesis gene cluster (our unpublished data), which
inevitably results in a membrane that is predominantly composed
of exogenous FAs (9).
It is tempting to speculate about the role of PCA in neutralizing
the detrimental effect of pneumococcal SpxB activity. In ambient
air, SpxB produces H2O2, acetyl-phosphate, and CO2. Production
of H2O2 leads to UFA peroxidation (31), whereas acetyl-phos-
phate can readily be converted to acetyl-CoA by phosphate
acetyl-transferase to support de novo FA biosynthesis. PCA then
acts to convert CO2 to HCO3
, allowing carboxylation of acetyl-
CoA to form malonyl-CoA. Currently, this hypothesis is not sup-
ported by our own observations, as catalase improved growth of
both the S. pneumoniae pca and pcaspxB strain cultures.
However, the interconnection between SpxB activity and FA bio-
synthesis is still poorly understood and might involve different
metabolic and regulatory pathways (31, 44). Alternatively, this
suggests that other sources of endogenous oxidative stress, such as
the Fenton reaction (31) or lactate oxidase activity (44), have a
profound impact on the growth arrest of the pca strains in
CO2-poor conditions as well.
The role of PCA in the de novo biosynthesis of UFAs and,
possibly, other metabolites could also explain the decreased
viability of the S. pneumoniae pca strains after invasion of
endothelial cells and uptake by macrophages. During phago-
cytosis, and possibly endocytosis (33), a substantial portion of
the intracellular bacteria is sorted to the host-cell lysosome.
The low pH of this compartment reduces HCO3
 availability,
and the production of ROS leads to peroxidation of bacterial
membrane UFAs (38) and nucleic acids (37). Interestingly, the
effect of pca disruption on S. pneumoniae invasion and intra-
cellular survival inside Detroit 562 pharyngeal epithelial cells
was not as pronounced as in the two other cell types. Whether
this difference reflects on the different routes for pneumo-
coccal invasion of Detroit 562 cells by interaction with
the polymeric immunoglobulin receptor (pIgR) (49) and
HBMECs by interaction with the platelet-activating factor re-
ceptor (PAFr) (34) remains to be studied. A role for microbial
carbonic anhydrases inside host cells was earlier suggested for
a Salmonella enterica serovar Typhimurium CA (mig-5), which
was expressed after uptake in macrophages and a mutant of
which had a marked decrease in spleen colonization of mice
(46). In contrast to findings for Salmonella CA mutants, we
were not able to link PCA with virulence in animal models of
bacteremia. However, this observation is in line with the out-
come of a previous study showing that mice deficient in the
NADPH oxidase subunit gp91, which is essential for lysosomal
ROS production, were as sensitive to pneumococcal infection
as wild-type mice (36). Furthermore, it is known that pneumo-
coccal capsular polysaccharides prevent recognition and up-
take of the bacterium by host immune cells, and once S. pneu-
moniae remains extracellular during infection of the blood, it
might utilize serum HCO3
 and FAs (9). Possibly, the role of
PCA in pneumococcal disease is more pronounced in animal
models of disease in which the bacterium needs to traverse the
boundaries of epithelial and endothelial cells for dissemination
from the respiratory tract to the blood and cerebrospinal fluid.
Finally, the role of PCA in S. pneumoniae can be projected
onto CAs in other (respiratory tract) pathogens. Although CAs
are ubiquitous enzymes in many microorganisms, most studies
have investigated the role of CAs that are exposed to the surface
or periplasm, have species-specific functions, or do not belong to
the class of -CAs (39). Here, we show that cytosolic -CAs
related to PCA are involved in FA biosynthesis and may offer
novel opportunities for the design of broad-range therapies. Fur-
thermore, PCA is probably only one of the factors that contribute
to the adaptation of S. pneumoniae to CO2-poor conditions,
which might be relevant for pneumococcal transmission in envi-
ronmental ambient air. Detailed examination of the metabolic
pathways that depend on PCA-mediated CO2 fixation and the
identification of the genetic basis for the CO2 dependence ob-
served in approximately 8% of all circulating pneumococcal iso-
lates is expected to lead to novel insights into the way respiratory
pathogens adapt to the CO2- and HCO3
-poor environments
they encounter during transmission, colonization, and disease.
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